Sequential hybrid ablation vs. surgical CryoMaze alone for treatment of atrial fibrillation: results of multicentre randomized controlled trial | Библиотека Института психологии РАН

Библиотека Института психологии РАН

Sequential hybrid ablation vs. surgical CryoMaze alone for treatment of atrial fibrillation: results of multicentre randomized controlled trial

Bulava Alan, Wichterle Dan, Mokráček Aleš, Osmančík Pavel, Budera Petr, Kačer Petr, Vetešková Linda, Němec Petr, Skála Tomáš, Šantavý Petr, Chovančík Jan, Branny Piotr, Rizov Vitalii, Kolesár Miroslav, Šafaříková Iva, Rybář Marian, Bulava Alan, Mokráček Aleš, Haniš Jiří, Hájek Přemysl, Šafaříková Iva, Sitek David, Novotný Adam, Osmančík Pavel, Kačer Petr, Heřman Dalibor, Rizov Vitalii, Süssenbek Ondřej, Wichterle Dan, Budera Petr, Szárszoi Ondrej, Salavec Lukáš, Peichl Petr, Kautzner Josef, Netuka Ivan, Ondrášek Jiří, Vetešková Linda, Němec Petr, Frantová Jana, Skála Tomáš, Šantavý Petr, Klimeš Dalibor, Majid Mariwan, Kolesár Miroslav, Červinka Pavel, Chovančík Jan, Branny Piotr, Jiravský Otakar
Europace SCOPUS WOS
ТИП ПУБЛИКАЦИИ статья в журнале - научная статья
ГОД 2024
ЯЗЫК EN
ЦИТИРОВАНИЙ 3
АННОТАЦИЯ
Abstract Aims Data on the hybrid atrial fibrillation (AF) treatment are lacking in patients with structural heart disease undergoing concomitant CryoMaze procedures. The aim was to assess whether the timely pre-emptive catheter ablation would achieve higher freedom from AF or atrial tachycardia (AT) and be associated with better clinical outcomes than surgical ablation alone. Methods and results The trial investigated patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement with mandatory concomitant CryoMaze procedure who were randomly assigned to undergo either radiofrequency catheter ablation [Hybrid Group (HG)] or no further treatment (Surgery Group). The primary efficacy endpoint was the first recurrence of AF/AT without class I or III antiarrhythmic drugs as assessed by implantable cardiac monitors. The primary clinical endpoint was a composite of hospitalization for arrhythmia recurrence, worsening of heart failure, cardioembolic event, or major bleeding. We analysed 113 and 116 patients in the Hybrid and Surgery Groups, respectively, with a median follow-up of 715 (IQR: 528–1072) days. The primary efficacy endpoint was significantly reduced in the HG [41.1% vs. 67.4%, hazard ratio (HR) = 0.38, 95% confidence interval (CI): 0.26–0.57, P < 0.001] as well as the primary clinical endpoint (19.9% vs. 40.1%, HR = 0.51, 95% CI: 0.29–0.86, P = 0.012). The trial groups did not differ in all-cause mortality (10.6% vs. 8.6%, HR = 1.17, 95%CI: 0.51–2.71, P = 0.71). The major complications of catheter ablation were infrequent (1.9%). Conclusion Pre-emptively performed catheter ablation after the CryoMaze procedure was safe and associated with higher freedom from AF/AT and improved clinical outcomes.
ЦИТАТА
Sequential hybrid ablation vs. surgical CryoMaze alone for treatment of atrial fibrillation: results of multicentre randomized controlled trial / A. Bulava, D. Wichterle, A. Mokráček, P. Osmančík, P. Budera, P. Kačer, L. Vetešková, P. Němec, T. Skála, P. Šantavý, J. Chovančík, P. Branny, V. Rizov, M. Kolesár, I. Šafaříková, M. Rybář, A. Bulava, A. Mokráček, J. Haniš, P. Hájek, I. Šafaříková, D. Sitek, A. Novotný, P. Osmančík, P. Kačer, D. Heřman, V. Rizov, O. Süssenbek, D. Wichterle, P. Budera, O. Szárszoi, L. Salavec, P. Peichl, J. Kautzner, I. Netuka, J. Ondrášek, L. Vetešková, P. Němec, J. Frantová, T. Skála, P. Šantavý, D. Klimeš, M. Majid, M. Kolesár, P. Červinka, J. Chovančík, P. Branny, O. Jiravský // Europace. – 2024. – Т. 26. – № 2. – P.
АВТОРЫ

Булава Александра Игоревна

ЛАБОРАТОРИЯ ПСИХОФИЗИОЛОГИИ имени В. Б. Швыркова
Младший научный сотрудник

Публикаций в поиске

72
СТРЕСС НАУЧЕНИЕ C-FOS

Булава Александра Игоревна

ЛАБОРАТОРИЯ ПСИХОФИЗИОЛОГИИ имени В. Б. Швыркова
Младший научный сотрудник

Публикаций в поиске

72
СТРЕСС НАУЧЕНИЕ C-FOS
ПОХОЖИЕ ПУБЛИКАЦИИ